Abstract:More than 2 decades of developments in the field have led to a wide variety of test kits available for addressing the different needs of surveillance, diagnosis, and monitoring of human immunodeficiency virus (HIV) infection and antiretroviral therapy (20, 23). These test kits are based on different tech- nologies, including immunoassays and molecular testing. Typ- ically, enzyme-linked immunosorbent assays (ELISAs) and rapid tests for detecting anti-HIV antibodies are used for blood screening and/or surveillance purposes. The former in- clude third-generation ELISAs that utilize the antigen sand- wich design for improved sensitivity, while the latter term re- fers to immunochromatographic tests or other simple antibody tests requiring less than 30 min of assay time. Since the viral capsid (core) p24 protein can be detected earlier than anti- HIV antibodies (93), attempts had also been made to develop a new generation of ELISA capable of simultaneously detect- ing the p24 antigen and anti-HIV antibodies (34, 52, 76, 101, 103). Significant reductions of the window period were achieved, which is ideal for blood screening and surveillance (102), but users were also advised to be mindful of possible limitations when utilizing such a combination assay (52, 81, 83). With specific panels, a delay in detection by a fourth- generation ELISA was evident compared with a dedicated p24 antigen assay (81). This shortcoming of fourth-generation ELISAs is understandable, because the surface area of the solid phase for detection is constant and limited regardless of whether it is utilized for a single test or combined assays (101). It should also be noted that an additional procedure for the dissociation of immune complexes employed by dedicated p24 antigen assays but not by combined assays was found to facil- itate sensitive detection (85). However, this does not mean that using ELISA dedicated for detecting p24 antigen has no short- comings. The viral p24 protein is a transient marker that can fall to an undetectable level after initial acute infection and only reemerges at the advanced stage of AIDS in patients (93, 107). Hence, tests utilizing this marker are more valuable for situations such as screening blood products from individuals before antibodies are produced, detecting early infections in persons who have been exposed but are seronegative, or mon-

Comparison of the Efficacy of HIV-1 p24 ELISA Kit and SIV p27 ELISA Kit in Detection of SIV p27 Antigen

Comparison of Three ELISA Kits for Detection of Mycoplasma Bovis Antibody

Improved Detection of HIV Gag p24 Protein Using a Combined Immunoprecipitation and Digital ELISA Method

[Comparative Evaluation of Hebei HIV-1 P24 Kit for the Detection of Human Immunodeficiency Virus].

Study on the correlations of P24 antigen, HIV DNA, HIV RNA in 139 HIV infected cases

Study on the Significance of S/Co Ratio of a Domestic Reagent Used for Anti-Hepatitis C Virus Antibody Detection

Comparison of Two ELISA Assays for the Detection of the Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Antibody and Its Application

Frequency, causes, and new challenges of indeterminate results in Western blot confirmatory testing for antibodies to human immunodeficiency virus.

The Evaluation of Elecsys HIV Combi Reagent in Detecting HIV Antigen and Antibody

Detection of HIV-1 P24 Antigen Using a Simple and Highly Sensitive Chemiluminescence Immunoassay

Development and Evaluation of A Line Immunoassay As A Confirmatory Test for Human Immunodeficiency Virus (Hiv)-1/2 Infections

Application of a commercial kit for detection of PCR products to quantification of human immunodeficiency virus type 1 RNA and proviral DNA

Clone of HIV-1 p24 gene and the pilot study of its toxicity to Chinese hamster ovary cells

[Comparison among Four Kits in Detection of Anti-Sars-cov IgG in Sera of SARS Patients].

Tracking detection of serial serum in early HIV-RNA positive cases by different methods

Expression, Purification and Identification of HIV-1 Gag P17 + 24 Recombinant Antigen

Comparison of the indirect immunofluorescence assay and a commercial ELISA to detect KSHV antibodies

Quantitative Detection of Anti-SARS-CoV-2 Antibodies Using Indirect ELISA

Anti-HIV-1 antibodies based confirmatory results in Wuhan, China, 2012-2018

[Correlation Between Signal/cutoff Ratios of Anti-Hcv Enzyme Immunoassay (EIA) and Their True Positivity in Blood Donors].

Estimation of the Seroconversion Duration of HIV-1 Antibodies in Individuals With Recent Infection in China